6505--Buspirone RFP
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0024
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Amber Zavala amber.zavala@va.gov (708) 786-5245
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center intends to issue a Request for Proposal (RFP) for Buspirone HCL Tablets, covering multiple federal agencies including VA, DOD, Bureau of Prisons, and Indian Health Service. The solicitation (36E79725R0024) is an unrestricted procurement seeking a single contractor to provide an uninterrupted supply of various Buspirone HCL tablet strengths. Key contract requirements include providing the exact drug name as it appears on the label, having a unique NDC number, and using child-resistant closures for bottles of 100 tablets or less. The solicitation will be electronically issued on or about 04/08/2025, with a tentative closing date of April 22, 2025. Interested offerors are advised to check http://www.sam.gov for updates and can direct questions to Amber Zavala at amber.zavala@va.gov.
The procurement has no specific set-aside designation and will cover a one-year base contract with four additional one-year option periods. Estimated annual requirements are substantial, ranging from 4,390 to 179,623 bottles across different dosages (5mg, 7.5mg, 10mg, 15mg, and 30mg). The contract will utilize VA and DOD Pharmaceutical Prime Vendor Programs for distribution. While specific award values are not detailed, the comprehensive requirements suggest a significant potential contract value. The NAICS code for this procurement is 325412 (Pharmaceutical Preparation Manufacturing), indicating the specific industry classification for potential bidders. The solicitation emphasizes that all responsible sources may submit an offer, with the VA planning to award to the offeror who can best ensure an uninterrupted supply of the required medication.
Notice text
Page 4 of 4
Page 4 of 4
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0024 for an unrestricted procurement for Buspirone HCL Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. All bottles of 100 tablets or less must have a child resistant closure. Glass bottles are not acceptable. Solicitation # 36E79725R0024 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 04/08/2025 with a tentative closing date of April 22, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov.
The estimated annual requirements are as follows:
Description Size Estimated Annual Requirements (Bottles)
BUSPIRONE HCL 10MG TAB 100 7,928
BUSPIRONE HCL 10MG TAB 500 179,623
BUSPIRONE HCL 15MG TAB 60 158,668
BUSPIRONE HCL 15MG TAB 500 74,023
BUSPIRONE HCL 30MG TAB 60 68,811
BUSPIRONE HCL 5MG TAB 100 4,390
BUSPIRONE HCL 5MG TAB 500 51,086
BUSPIRONE HCL 7.5MG TAB 100 42,775
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79725R0024_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Buspirone Award | Award Notice | |
| 6505--Buspirone RFP | Solicitation | |
| 6505--Buspirone RFP | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity